Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Combination of Irinotecan and Temozolomide in Children With Brain Tumors.

NCT00404495

Conditions: Glioma, Medulloblastoma, Neoplasms, +7 more
Locations: Pfizer Investigational Site Westmead, New South Wales, Australia

Pfizer Investigational Site Herston, Queensland, Australia

Pfizer Investigational Site Parkville, Victoria, Australia

Pfizer Investigational Site Ghent, Belgium

View all 29 locations

View Trial Details

Completed

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

NCT00132158

Conditions: Astrocytoma, Glioblastoma, Glioma, +19 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

NCT01285414

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations: Stanford University Stanford, California, United States

University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Completed

Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents

NCT00147160

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Institut Gustave-Roussy Villejuif, France

Bristol Royal Hospital for Children Bristol, United Kingdom

View Trial Details

Completed

Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma

NCT01052142

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Pain & Anaesthesia Research Clinic Adelaide, South Australia, Australia

View Trial Details

Completed

89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors

NCT01338090

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University Medical Center Groningen Groningen, Netherlands

View Trial Details

Completed

Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer

NCT00436657

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +52 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Measuring Non-Enhancing Glioblastoma Progression

NCT00777686

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

NCT00828126

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

NCT00019786

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +38 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions